Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    1688381 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
2 Completed AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Conditions: Refractory or Recurrent Solid Tumors;   Acute Myelogenous Leukemia
Intervention: Drug: Cediranib, AZD2171, RECENTIN
3 Completed Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Biological: Bevacizumab
4 Terminated Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Esophageal Neoplasms;   Esophageal Diseases
Interventions: Drug: Erlotinib;   Drug: Avastin

Indicates status has not been verified in more than two years